by By Jonathan Paye-Layleh
Liberians are overcoming their fears of Ebola to volunteer for a vaccine trial.
The gruesome toll of West Africa's Ebola outbreak, which has killed more than 4,200 Liberians of the more than 10,000 who have succumbed to the disease, has intensified efforts to find a vaccine for a disease that previously infected relatively few people in remote areas.
One year after the World Health Organization declared the Ebola outbreak, vaccine trials are under way in Liberia and Guinea. Sierra Leone will start a trial later this month.
In Liberia, scientists have fanned out across the country to explain the studies and reduce the fear and confusion that have stymied efforts to contain Ebola.
Dr. Stephen Kennedy, the Liberian lead investigator for the study, was among the first people to volunteer for the vaccine trial, getting his injection in front of the media. Similarly, in Guinea, authorities started the study by injecting a series of prominent officials, including the head of the country's Ebola response.
The outreach worked in Liberia, where more than 700 people have volunteered, well beyond the 600 required, according to Kennedy.
"All of the reservations I have were explained, my doubts were cleared," B. Emmanuel Lansana, a physician's assistant who was the first person to participate in the study, said after he received his injection.
Enrollment will close soon for Liberia's Phase 2 trial, which is testing two vaccine candidates for safety and for whether they produce an immune response.
"We've had no trouble with enrollment," said Dr. Clifford Lane, the clinical director of the U.S. National Institute of Allergy and Infectious Diseases, which is helping to run the study. "This study has been pulled off in an extraordinarily professional, competent and efficient way."
Liberia had not seen an Ebola case in weeks before one was confirmed Friday. The low level of the disease means that the trial's next phase may be moved to Sierra Leone or Guinea where the disease is more prevalent, Lane said. Phase 3 tests whether the vaccines actually prevent Ebola, so it must be done in a place with active transmission.
Doubters remain in Liberia, of course. A community chalkboard at a busy intersection in Monrovia recently read: "Ebola vaccines 1 vs. Public fear 4."
Drame Musokulamohadi, a student who cuts hair on the outskirts of the capital, hissed twice when asked about the vaccine before declaring: "I don't get myself associated with anything that is associated with Ebola."
But because the initial phase of the trial in Liberia only needed a few hundred people, the pockets of mistrust are not a hindrance.
Guinea could provide a stiffer test. In addition to vaccinating about 1,500 health workers, investigators will test vaccines by offering injections to whole communities around select Ebola cases as early as this week. That will require getting a high-level of participation; about 60 percent compliance is hoped for, said Dr. Marie-Paule Kieny, who leads Ebola vaccine research at the World Health Organization.
"I don't want to say that everything is rosy," she said, but recently resistance to Ebola control efforts seems to have been falling off in Guinea. "I hope we will be able to surf on this."
Explore further: Liberia investigates how latest Ebola patient got infected
© 2015 The Associated Press. All rights reserved.
Medical Xpress on facebook
Related Stories
Liberia investigates how latest Ebola patient got infected
Mar 21, 2015
Liberian officials were investigating Saturday how the country's latest Ebola patient became infected, after weeks with no cases of the disease in the country.
Ebola vaccine tests to begin in Guinea on March 7: WHO
Mar 05, 2015
The first large-scale trial of an Ebola vaccine will begin in Guinea at the weekend, the World Health Organization said Thursday, weeks after a similar test kicked off in neighbouring Liberia.
Liberia officials: New patient tests positive for Ebola
Mar 20, 2015
A patient has tested positive for Ebola in Liberia's capital, officials said Friday, deflating hopes that the West African nation had beaten the disease after weeks with no new cases.
Liberia: Only five people being treated for Ebola in country
Jan 26, 2015
Liberia said Monday that there are currently only five confirmed cases of Ebola in the entire country—a dramatic turnaround in the West African nation where the virus has taken its deadliest toll.
Sierra Leone plans another shutdown to stop Ebola's spread
Mar 18, 2015
Sierra Leone is planning another three-day, countrywide shutdown later this month to ferret out Ebola cases, remind people how to protect themselves from the disease and control its transmission.
Recommended for you
Sierra Leone orders three-day lockdown against Ebola (Update)
18 hours ago
Sierra Leone's President Ernest Koroma ordered the country's entire population Saturday to stay in their homes for three days in a bid to stem the spread of the deadly Ebola epidemic.
Liberia investigates how latest Ebola patient got infected
Mar 21, 2015
Liberian officials were investigating Saturday how the country's latest Ebola patient became infected, after weeks with no cases of the disease in the country.
Liberia officials: New patient tests positive for Ebola
Mar 20, 2015
A patient has tested positive for Ebola in Liberia's capital, officials said Friday, deflating hopes that the West African nation had beaten the disease after weeks with no new cases.
More than 25 percent of acne patients fail to get prescribed medications
Mar 20, 2015
Medicine obviously can't do much good if it sits on a pharmacy shelf. Yet more than one-quarter of the acne patients surveyed by Wake Forest Baptist Medical Center researchers didn't get medications prescribed by their dermatologists.
CDC: Decline in TB rates in the united states slowing down
Mar 20, 2015
(HealthDay)—As health officials in Kansas struggle with an outbreak of tuberculosis (TB) at a local high school, federal officials reported Thursday that the annual decline in U.S. cases is slowing. The ...
Scientists must reduce antibiotic use in experiments
Mar 20, 2015
Scientists should reduce antibiotic use in lab experiments - according to a researcher at the University of East Anglia.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
by By Jonathan Paye-Layleh
Liberians are overcoming their fears of Ebola to volunteer for a vaccine trial.
The gruesome toll of West Africa's Ebola outbreak, which has killed more than 4,200 Liberians of the more than 10,000 who have succumbed to the disease, has intensified efforts to find a vaccine for a disease that previously infected relatively few people in remote areas.
One year after the World Health Organization declared the Ebola outbreak, vaccine trials are under way in Liberia and Guinea. Sierra Leone will start a trial later this month.
In Liberia, scientists have fanned out across the country to explain the studies and reduce the fear and confusion that have stymied efforts to contain Ebola.
Dr. Stephen Kennedy, the Liberian lead investigator for the study, was among the first people to volunteer for the vaccine trial, getting his injection in front of the media. Similarly, in Guinea, authorities started the study by injecting a series of prominent officials, including the head of the country's Ebola response.
The outreach worked in Liberia, where more than 700 people have volunteered, well beyond the 600 required, according to Kennedy.
"All of the reservations I have were explained, my doubts were cleared," B. Emmanuel Lansana, a physician's assistant who was the first person to participate in the study, said after he received his injection.
Enrollment will close soon for Liberia's Phase 2 trial, which is testing two vaccine candidates for safety and for whether they produce an immune response.
"We've had no trouble with enrollment," said Dr. Clifford Lane, the clinical director of the U.S. National Institute of Allergy and Infectious Diseases, which is helping to run the study. "This study has been pulled off in an extraordinarily professional, competent and efficient way."
Liberia had not seen an Ebola case in weeks before one was confirmed Friday. The low level of the disease means that the trial's next phase may be moved to Sierra Leone or Guinea where the disease is more prevalent, Lane said. Phase 3 tests whether the vaccines actually prevent Ebola, so it must be done in a place with active transmission.
Doubters remain in Liberia, of course. A community chalkboard at a busy intersection in Monrovia recently read: "Ebola vaccines 1 vs. Public fear 4."
Drame Musokulamohadi, a student who cuts hair on the outskirts of the capital, hissed twice when asked about the vaccine before declaring: "I don't get myself associated with anything that is associated with Ebola."
But because the initial phase of the trial in Liberia only needed a few hundred people, the pockets of mistrust are not a hindrance.
Guinea could provide a stiffer test. In addition to vaccinating about 1,500 health workers, investigators will test vaccines by offering injections to whole communities around select Ebola cases as early as this week. That will require getting a high-level of participation; about 60 percent compliance is hoped for, said Dr. Marie-Paule Kieny, who leads Ebola vaccine research at the World Health Organization.
"I don't want to say that everything is rosy," she said, but recently resistance to Ebola control efforts seems to have been falling off in Guinea. "I hope we will be able to surf on this."
Explore further: Liberia investigates how latest Ebola patient got infected
© 2015 The Associated Press. All rights reserved.
Medical Xpress on facebook
Related Stories
Liberia investigates how latest Ebola patient got infected
Mar 21, 2015
Liberian officials were investigating Saturday how the country's latest Ebola patient became infected, after weeks with no cases of the disease in the country.
Ebola vaccine tests to begin in Guinea on March 7: WHO
Mar 05, 2015
The first large-scale trial of an Ebola vaccine will begin in Guinea at the weekend, the World Health Organization said Thursday, weeks after a similar test kicked off in neighbouring Liberia.
Liberia officials: New patient tests positive for Ebola
Mar 20, 2015
A patient has tested positive for Ebola in Liberia's capital, officials said Friday, deflating hopes that the West African nation had beaten the disease after weeks with no new cases.
Liberia: Only five people being treated for Ebola in country
Jan 26, 2015
Liberia said Monday that there are currently only five confirmed cases of Ebola in the entire country—a dramatic turnaround in the West African nation where the virus has taken its deadliest toll.
Sierra Leone plans another shutdown to stop Ebola's spread
Mar 18, 2015
Sierra Leone is planning another three-day, countrywide shutdown later this month to ferret out Ebola cases, remind people how to protect themselves from the disease and control its transmission.
Recommended for you
Sierra Leone orders three-day lockdown against Ebola (Update)
18 hours ago
Sierra Leone's President Ernest Koroma ordered the country's entire population Saturday to stay in their homes for three days in a bid to stem the spread of the deadly Ebola epidemic.
Liberia investigates how latest Ebola patient got infected
Mar 21, 2015
Liberian officials were investigating Saturday how the country's latest Ebola patient became infected, after weeks with no cases of the disease in the country.
Liberia officials: New patient tests positive for Ebola
Mar 20, 2015
A patient has tested positive for Ebola in Liberia's capital, officials said Friday, deflating hopes that the West African nation had beaten the disease after weeks with no new cases.
More than 25 percent of acne patients fail to get prescribed medications
Mar 20, 2015
Medicine obviously can't do much good if it sits on a pharmacy shelf. Yet more than one-quarter of the acne patients surveyed by Wake Forest Baptist Medical Center researchers didn't get medications prescribed by their dermatologists.
CDC: Decline in TB rates in the united states slowing down
Mar 20, 2015
(HealthDay)—As health officials in Kansas struggle with an outbreak of tuberculosis (TB) at a local high school, federal officials reported Thursday that the annual decline in U.S. cases is slowing. The ...
Scientists must reduce antibiotic use in experiments
Mar 20, 2015
Scientists should reduce antibiotic use in lab experiments - according to a researcher at the University of East Anglia.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment